Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-18T01:57:43.600Z Has data issue: false hasContentIssue false
  • English
  • Français

Factors Associated with Adherence to Transdermal Nicotine Patches within a Smoking Cessation Effectiveness Trial‡

Published online by Cambridge University Press:  09 March 2017

Jonnie Handschin ,
Brian Hitsman ,
Sonja Blazekovic ,
Anna Veluz-Wilkins ,
E. Paul Wileyto ,
Frank T. Leone ,
Rebecca L. Ashare  and
Robert A. Schnoll
Jonnie Handschin*
Affiliation:
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Pennsylvania
Brian Hitsman
Affiliation:
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
Sonja Blazekovic
Affiliation:
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Pennsylvania
Anna Veluz-Wilkins
Affiliation:
Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
E. Paul Wileyto
Affiliation:
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Pennsylvania
Frank T. Leone
Affiliation:
Pulmonary, Allergy, & Critical Care Division, Penn-Presbyterian Medical Center, University of Pennsylvania, Pennsylvania
Rebecca L. Ashare
Affiliation:
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Pennsylvania
Robert A. Schnoll
Affiliation:
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Pennsylvania
*
Address for correspondence: Jonnie Handschin, BS, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104. Email: jhands@mail.med.upenn.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction: Adherence to transdermal nicotine patches, one of the most popular and effective treatments for nicotine dependence, remains very low and is a strong predictor of cessation rates.

Aims: This study examined individual factors related to adherence as well as differences over time between adherent (>85% of daily patch use) and non-adherent participants (<85% of daily patch use).

Methods: We analysed data from 440 participants who received 8 weeks of 21 mg transdermal nicotine and four behavioural counselling sessions within an effectiveness trial that examined the effects of long-term treatment. Multiple logistical regression assessed baseline variables associated with patch adherence and generalised estimating equations (GEE) were used to evaluate changes in craving and withdrawal, depressive and anxiety symptoms, substitute and complementary reinforcers, and side effects between participants who were or were not adherent.

Results: Adherence to patch use was strongly associated with smoking cessation at week 8 (p < 0.05). In a logistic regression model, being female, living with a child or children, and higher self-reported anxiety symptoms were predictive of lower patch adherence (p < 0.05). In the GEE analysis, adherence was significantly associated with a greater reduction in craving, a greater engagement in substitute reinforcers, and a greater decrease in complementary reinforcers over time (p < 0.05).

Conclusions: Difficulties adhering to transdermal nicotine patches may be related to psychiatric comorbidity, difficulty managing nicotine craving, and challenges with engaging in substitute reinforcers and reducing exposure to complementary reinforcers. These constructs may serve as targets for interventions designed to increase treatment adherence.

Trial registration: ClinicalTrials.gov Identifier: NCT01047527

Type
Original Articles
Information
Journal of Smoking Cessation , Volume 13 , Issue 1 , March 2018 , pp. 33 - 43
Copyright
Copyright © The Author(s) 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

‡

The original version of this article was published with an incorrect author name. A notice detailing this has been published and the error rectified in the online PDF and HTML copies

References

Acker, J., & MacKillop, J. (2013). Behavioral economic analysis of cue-elicited craving for tobacco: A virtual reality study. Nicotine & Tobacco Research, 15, 1409–1416. doi:10.1093/ntr/nts341.CrossRefGoogle ScholarPubMed
al'Absi, M., Carr, S. B., & Bongard, S. (2007). Anger and psychobiological changes during smoking abstinence and in response to acute stress: Prediction of smoking relapse. International Journal of Psychophysiology, 66, 109–115. doi:10.1016/j.ijpsycho.2007.03.016 CrossRefGoogle ScholarPubMed
Alterman, A. I., Gariti, P., Cook, T. G., & Cnaan, A. (1999). Nicodermal patch adherence and its correlates. Drug and Alcohol Dependence, 53, 159–165. doi: 10.1016/S0376-8716(98)00124-0.CrossRefGoogle ScholarPubMed
Baker, T. B., Piper, M. E., Stein, J. H., Smith, S. S., & Fiore, M. C. (2016). Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessaation at 26 weeks: A randomized clinical trial. Journal of American Medicine, 315, 371–379. doi: 10.1001/jama.2015. 19284 Google ScholarPubMed
Balmford, J., Borland, R., Hammond, D., & Cummings, K. M. (2011). Adherence to and reasons for premature discontinuation from stop-smoking medications: Data from the ITC four-country survey. Nicotine & Tobacco Research, 13, 94–102. doi:10.1093/ntr/ntq215.CrossRefGoogle ScholarPubMed
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893–897. doi:10.1037/0022-006X.56.6.893 CrossRefGoogle ScholarPubMed
Berg, C. J., Ahluwalia, J. S., & Cropsey, K. (2013). Predictors of adherence to behavioral counseling and medication among female prisoners enrolled in a smoking cessation trial. Journal of Correctional Health Care, 19, 236–247. doi:10.1177/1078345813499307.CrossRefGoogle Scholar
Brown, R., Burgess, E., Sales, S., & Whiteley, J. (1998). Reliability and validity of a smoking timeline follow-back interview. Psychology of Addictive Behaviors, 12, 101–112. doi:10.1037/0893-164X.12.2.101.CrossRefGoogle Scholar
Catz, S. L., Jack, L. M., McClure, J. B., Javitz, H. S., Deprey, M., Zbikowski, S. M., et al. (2011). Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine & Tobacco Research, 13, 361–368. doi: 10.1093/ntr/ntr003 CrossRefGoogle ScholarPubMed
Chung, M. L., Moser, D. K., Lennie, T. A., Worrall-Carter, L., Bentley, B., Trupp, R., et al. (2010). Gender differences in adherence to the sodium-restricted diet in patients with heart failure. Journal of Cardiac Failure, 12, 628–634. doi: 10.1016/j.cardfail.2006.07.007 CrossRefGoogle Scholar
Cooper, T. V., DeBon, M. W., Stockton, M., Klesges, R. C., Steenbergh, T. A., Sherrill-Mittleman, D., et al. (2004). Correlates of adherence with transdermal nicotine. Addictive Behaviors, 29, 1565–1578. doi:10.1016/j.addbeh.2004.02.033 CrossRefGoogle ScholarPubMed
Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001). Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research, 3, 7–16. doi:10.1080/14622200124218 CrossRefGoogle ScholarPubMed
Daly, J., Sindone, A. P., Thompson, D. R., Hancock, K., Chang, E., & Davidson, P. (2002). Barriers to participation in and adherence to cardiac rehabilitation programs: A critical literature review. Progress in Cardiovascular Nursing, 17, 8–17. doi: 10.1111/j.0889-7204.3003.00614.x CrossRefGoogle ScholarPubMed
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101–2107. doi:10.1001/archinte.160.14.2101 CrossRefGoogle ScholarPubMed
Etter, J. F., & Perneger, T. V. (2001). Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public. Clinical Pharmacology & Therapeutics, 69, 175–183. doi:10.1067/mcp.2001.113722.CrossRefGoogle ScholarPubMed
Fiore, M. C., Jaen, C. R., Baker, T., Bailey, W. C., Benowitz, N. L., Curry, S. J., et al. (2008). Treating tobacco use and dependence: 2008 update. Rockville, MD: US Department of Health and Human Services.Google Scholar
Goelz, P. M., Audrain-McGovern, J. E., Hitsman, B., Leone, F. T., Veluz-Wilkins, A., Jepson, C., et al. (2014). The association between changes in alternative reinforcers and short-term smoking cessation. Drug and Alcohol Dependence, 138, 67–74. doi: 10.1016/j.drugalcdep.2014.02.007.CrossRefGoogle ScholarPubMed
Green, L., & Freed, D. E. (1993). The substitutability of reinforcers. Journal of the Experimental Analysis of Behavior, 60, 141–158. doi:10.1901/jeab.1993.60-141 CrossRefGoogle ScholarPubMed
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The fagerström test for nicotine dependence: A revision of the fagerström tolerance questionnaire. British Journal of Addiction, 86, 1119–1127.CrossRefGoogle ScholarPubMed
Hollands, G. J., McDermott, M. S., Lindson-Hawley, N., Vogt, F., Farley, A., & Aveyard, P. (2015). Interventions to increase adherence to medications for tobacco dependence. The Cochrane Library. (2):CD009164.Google Scholar
Hollands, G. J., Sutton, S., McDermott, M. S., Marteau, T. M., & Aveyard, P. (2013). Adherence to and consumption of nicotine replacement therapy and the relationship with abstinence within a smoking cessation trial in primary care. Nicotine & Tobacco Research, 15, 1537–1544. doi:10.1093/ntr/ntt010.CrossRefGoogle ScholarPubMed
Horn, D., & Waingrow, S. (1966). Some dimensions of a model for smoking behavior change. American Journal of Public Health and the Nation's Health, 56, 21–26. doi:10.2105/AJPH.56.12_Suppl.21 CrossRefGoogle Scholar
Hughes, J. R., Hatsukami, D. K., Pickens, R. W., Krahn, D., Malin, S., & Luknic, A. (1984). Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology, 83, 82–87. doi:10.1007/BF00427428 CrossRefGoogle ScholarPubMed
Jarvis, M. (1994). Gender differences in smoking cessation: Real or myth?. Tobacco Control, 3, 324–328.CrossRefGoogle Scholar
Kaufmann, A., Hitsman, B., Goelz, P. M., Veluz-Wilkins, A., Blazekovic, S., Powers, L., et al. (2015). Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers. Addictive Behaviors, 51, 93–99. doi:10.1016/j.addbeh. 2015.07.019 CrossRefGoogle Scholar
Leventhal, A. M., & Zvolensky, M. J. (2015). Anxiety, depression, and cigarette smoking: A transdiagnostic vulnerability framework to understanding emotion–smoking comorbidity. Psychological Bulletin, 141, 176. doi:10.1037/bul0000003.CrossRefGoogle ScholarPubMed
Lewey, J., Shrank, W. H., Bowry, A. D., Kilabuk, E., Brennan, T. A., & Choudhry, N. K. (2013). Gender and racial disparities in adherence to statin therapy: A meta-analysis. American Heart Journal, 165, 665–678. doi: 10.1016/j.ahj.2013.02. 011 CrossRefGoogle ScholarPubMed
MacKillop, J., Brown, C. L., Stojek, M. K., Murphy, C. M., Sweet, L., & Niaura, R. S. (2012). Behavioral economic analysis of withdrawal-and cue-elicited craving for tobacco: An initial investigation. Nicotine & Tobacco Research, 14, 1426–1434. doi:10.1093/ntr/nts006.CrossRefGoogle ScholarPubMed
MacPhillamy, D. J., & Lewinsohn, P. M. (1982). The pleasant events schedule – studies on reliability, validity, and scale intercorrelation. Journal of Consulting and Clinical Psychology, 50, 363–380. doi:10.1037/0022-006X.50.3.363 CrossRefGoogle Scholar
Niaura, R., Britt, D. M., Shadel, W. G., Goldstein, M., Abrams, D., & Brown, R. (2001). Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychology of Addictive Behaviors, 15, 13–17. doi:10.1037/0893-164X.15.1.13 CrossRefGoogle ScholarPubMed
Osterberg, L., & Blaschke, T. (2005). Adherence to medication. New England Journal of Medicine, 353, 487–497. doi: 10.1056/NEJMra050100 CrossRefGoogle ScholarPubMed
Perkins, K. A., & Scott, J. (2008). Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine & Tobacco Research, 10, 1245–1251. doi:10.1080/14622200802097506.CrossRefGoogle ScholarPubMed
Rush, A. J., Giles, D. E., Schlesser, M. A., Fulton, C. L., Weissenburger, J. & Burns, C. (1986). The Inventory of Depressive Symptomatology (IDS) – preliminary findings. Psychiatry Research, 18, 65–87. doi:10.1016/0165-1781(86)90060-0 CrossRefGoogle ScholarPubMed
Schnoll, R. A., Goelz, P. M., Veluz-Wilkins, A., Blazekovic, S., Powers, L., Leone, F. T., et al. (2015). Long-term nicotine replacement therapy: A randomized clinical trial. JAMA Internal Medicine, 175, 504–511. doi:10.1001/jamainternmed.2014.8313.CrossRefGoogle ScholarPubMed
Schnoll, R. A., Hitsman, B., Blazekovic, S., Veluz-Wilkins, A., Wileyto, E. P., Leone, F. T., et al. (in press). Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes. Drug and Alcohol Dependence 165, 245–52.CrossRefGoogle Scholar
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janays, J., Weiller, E., et al. (1998). The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22–33.Google ScholarPubMed
Shiffman, S., Brockwell, S. E., Pillitteri, J. L., & Gitchell, J. G. (2008). Use of smoking-cessation treatments in the United States. American Journal of Preventative Medicine, 34, 102–111. doi:10.1016/j.amepre.2007.09.033.CrossRefGoogle ScholarPubMed
SRNT Subcommittee on Biochemical Verification. (2002). Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research, 4, 149–159. doi:10.1080/14622200210123581.CrossRefGoogle Scholar
Stead, L. F., Bergson, G., & Lancaster, T. (2008). Physician advice for smoking cessation. The Cochrane Library (2):CD000165.Google Scholar
Swan, G. E., McAfee, T., Curry, S. J., Jack, L. M., Javitz, H., Dacey, S., et al. (2003). Effectiveness of bupropion sustained release for smoking cessation in a health care setting; A randomized rrial. Archives of Internal Medicine, 163, 2337–2344. doi: 10.1001/archinte.163.19.2337 CrossRefGoogle Scholar
Swan, G. E., Ward, M. M., & Jack, L. M. (1996). Abstinence effects as predictors of 28-day relapse in smokers. Addictive Behaviors, 21, 481–490. doi:10.1016/0306-4603(95)00070-4 CrossRefGoogle ScholarPubMed
Toll, B. A., McKee, S. A., Martin, D. J., Jatlow, P., & O'Malley, S. S. (2007). Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit. Nicotine & Tobacco Research, 9, 597–605. doi:10.1080/14622200701239662 CrossRefGoogle ScholarPubMed
West, R., McNeill, A., & Raw, M. (2000). Smoking cessation guidelines for health professionals: An update. Thorax, 55, 987–999. doi:10.1136/thorax.55.12.987 CrossRefGoogle ScholarPubMed
Wetter, D. W., Fiore, M. C., Young, T. B., McClure, J. B., de Moor, C. A., & Baker, T. B. (1999). Gender differences in response to nicotine replacement therapy: Objective and subjective indexes of tobacco withdrawal. Experimental and Clinical Psychopharmacology, 7, 135–144. doi:10.1037/1064-1297.7.2.135 CrossRefGoogle ScholarPubMed